Evidence map›Paper›PMID 37291682›Full record

ReviewParasites & vectors2023

Leishmania (Viannia) naiffi Lainson & Shaw 1989.

Lilian Motta Cantanhêde, Elisa Cupolillo

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Parasites & vectors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Lilian Motta CantanhêdeLeishmaniasis Research Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil. lilian.cantanhede@fiocruz.br.
Elisa CupolilloLeishmaniasis Research Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Departamento de Ciência e Tecnologia · BRDepartamento de Epidemiología · GT

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico Research Fellow, 302622/2017-9Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance Code 001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro CNE, E26-202.569/2019; Temáticos, E26-210.038/2020Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro Pós-Doutorado Nota 10 (E-26/205.730/2022 e 205.731/2022)
6 · The paper itself

Abstract

Just over 30 years ago, a new species of Leishmania of the subgenus Leishmania (Viannia) was described infecting the armadillo Dasypus novemcinctus; then, a report of human infection followed. From the Brazilian Amazon and apparently restricted to this region and its close borders, Leishmania (Viannia) naiffi has been characterized as a species that grows easily in axenic culture medium and causes few to no lesions after inoculation in experimental animal models. Results in the last decade indicate the occurrence of L. naiffi in vectors and human infections, including a report of therapeutic failure possibly associated with Leishmania RNA virus 1. Overall, such accounts suggest that the parasite is more dispersed and the disease less self-healing than previously expected.

Indexed as

LeishmaniaAnimalsArmadillosBrazilHumansClinical outcomesEpidemiologyLeishmania (Viannia) naiffi

Identifiers

PMID37291682
PMCPMC10251559
OpenAlexW4379878315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.